phone icon
+44 (0)1223 298875

Anti-Ataxin-1 Antibody

file icon Datasheet
Description: Rabbit polyclonal antibody to Ataxin-1.
Category: Primary Antibodies
Applications: WB, IF
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Reactivity: Human
UniProt: P54253
Gene ID: 6310
Immunogen: A synthetic peptide of human ATXN1
Protein Length: 815
Formulation: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Synonyms: Ataxin-1; Spinocerebellar ataxia type 1 protein; ATXN1; ATX1; SCA1
Purification: Affinity purification
Background: Spinocerebellar ataxia 1 (SCA1), an autosomal dominant neurodegenerative disorder, is characterized by slurred speech, loss of limb coordination, and gait abnormalities resulting from the degeneration of cerebellar Purkinje cells and of a subset of brainstem neurons (1). Individuals with SCA1 have a highly polymorphic CAG repeat expansion encoding a polyglutamine tract in ataxin-1 (2). Akt phosphorylates ataxin-1 at Ser776, which regulates an association with 14-3-3. This interaction increases ataxin-1 stabilization and accumulation resulting in enhanced neurodegeneration (3). In addition, HSP70 controls the effect that phosphorylation has on ataxin-1 stability (4).
Storage: Store at 4℃. Avoid freeze / thaw cycles.
Recommended Dilutions: WB 1:200 - 1:500, IF 1:20 - 1:50

Target (Information from UniProt)
Function: Chromatin-binding factor that repress Notch signaling in the absence of Notch intracellular domain by acting as a CBF1 corepressor. Binds to the HEY promoter and might assist, along with NCOR2, RBPJ-mediated repression. Binds RNA in vitro. May be involved in RNA metabolism.
Tissue Specificity: Widely expressed throughout the body.
Involvement in Disease: Spinocerebellar ataxia 1: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA1 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA1 is caused by expansion of a CAG repeat in the coding region of ATXN1. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.
Sequence Similarities: Belongs to the ATXN1 family.
Post-Translational Modification: Ubiquitinated by UBE3A, leading to its degradation by the proteasome. The presence of expanded poly-Gln repeats in spinocerebellar ataxia 1 (SCA1) patients impairs ubiquitination and degradation, leading to accumulation of ATXN1 in neurons and subsequent toxicity.
Cellular Location: Cytoplasm. Nucleus.

Colocalizes with USP7 in the nucleus.

Western Blot - Anti-Ataxin-1 Antibody from ABclonal (A0506) - Antibody Supply Service
Western blot analysis of CEM cell lysate using ATXN1 antibody.

Product Code - A0506
Size Price Quantity
100µl £243
200µl £372

Request a quotation
Contact us directly to order
  • call icon +44 (0)1223 298875
  • +44 (0)1223 281447
  • email icon
Product Quality
  • guarantee icon
  • We promise guaranteed product quality
  • and expert customer service.
Shipping Information
  • £20 to United Kingdom
  • £35 to Europe